Crosslinking of ultrapure hemoglobin, crystalline catalase, and superoxide dismutase resulted in a soluble nanodimensional complex of polyhemoglobin-catalase-superoxide dismutase. A less expensive and more convenient way is to crosslink bovine stromafree hemolysate (stroma-free hemolysate) that already contains hemoglobin, catalase, and superoxide dismutase into polyhemoglobin with catalase and superoxide dismutase activities (stroma-free polyhemolysate) [21]. The objective of the present study is to evaluate the immunological properties of this stroma-free polyhemolysate. Each of three groups of rats received weekly subcutaneous injections of one of the stroma-free polyhemolysate, stroma-free hemolysate, and saline for four weeks. One week after the four cycles of weekly immunization, serum and plasma were collected for C3a complement activation tests and Ouchterlony antibody-antigen precipitation tests, respectively. Results show that stroma-free polyhemolysate retained signifi cant antioxidant enzyme activity. The C3a complement activation test and Ouchterlony test show that four weekly subcutaneous injections of bovine stroma-free polyhemolysate did not result in any immunological reaction in rats when tested this way.
INTRODUCTION
Red blood cell substitutes are oxygen carriers designed to temporarily replace transfused blood. The potential benefi ts of a RBC substitute include universal compatibility, immediate availability, freedom from disease trans- In certain clinical situations, such as in sustained severe hemorrhagic shock, stroke, and myocardial infarction, the use of poly-Hb might result in ischemia reperfusion injuries [2, 6, 8, 13] . Ischemia occurs when there is a lack of oxygen supply to an organ or tissue, which leads to the accumulation of xanthine and hypoxanthine and also promotes the conversion of enzyme xanthine dehydrogenase to its oxidase form. When reperfused with oxygen carrier, xanthine oxidase converts xanthine and hypoxanthine into superoxide and other reactive oxygen species. This can lead to reperfusion injuries [13] . Recently, a nanobiotechnological method has been used to prepare a soluble complex of polyHb-catalasesuperoxidase dismutase (PolyHb-CAT-SOD) containing higher concentration of these antioxidase enzymes than those normally present in red blood cells [7, 8, 9, 13] . Animal studies show that PolyHb-CAT-SOD significantly decreases oxygen radical production and ischemia reperfusion injuries [7, 8, 9, 12, 29, 31] .
This PolyHb-SOD-CAT was prepared from ultrapure hemoglobin, catalase (CAT), and superoxide dismutase (SOD) [13] . The high costs of these purifi ed enzymes and Hb are not practical for large-scale manufacturing. The origi nal use of stroma-free content of red blood cells (stroma-free hemolysate ) for preparing different types of blood sub stitutes [4, 5] would be more practical. Our recent analysis of glutaraldehyde cross-linking of stromafree hemolysate shows good retention of hemoglobin, SOD and CAT acti vity [21] . However, the immunological properties of this preparation need to be analyzed. The objective of the present study is therefore to evaluate the immunological properties of bovine stroma-free polyhemolysate prepared this way when injected subcutaneously into rats. C3a complement activation tests and Ouchterlony tests show that four weekly subcutaneous injections of bovine stroma-free polyhemolysate did not result in any immunological reaction in rats when tested this way.
MATERIALS

Materials
The following materials were purchased from different sources as shown: fresh bovine blood (McGill University, MacDonald campus), NaCl (Fisher), Potassium Phosphate (Sigma), Toluene (Sigma), Sodium Phosphate (Sigma), 99% Lysine Monohydrochloride (Sigma), 25% Glutaraldehyde (Sigma), 1.5cm*98cm Chromatography Column (Fisher), Sepacryl S-300HR (Sigma), Tris Base (Sigma), 37% Hydrochloric Acid (Sigma), Catalase from bovine liver (Sigma), Superoxide Dismuatase from bovine erythrocyte (Sigma), 30% Brij 35 solution (Sigma), Drabkin (Sigma), Molecular Weight Marker Kit (29,000-700,000) (Sigma), UltraPure Water (Cay- 
Animals
Male Sprague-Dawley rats (250-300 g) (Charles River) were housed in a 12-hour light cycle environment in the McIntyre Animal Facility and were provided with food and water ad libitum. The experimental protocol was approved by the animal resources center of McGill University and met the Canadian Council on Animal Care guidelines for animal use.
METHODS
Stroma-free Hemolysate Preparation
This follows that of Gu and Chang [21] with slight variations. Fresh bovine blood with heparin (anticoagulant) was centrifuged at 4000ϫg for 60 minutes at 4 o C. After removal and plasma supernatant and upper layer of cell pellet, the blood cells were washed four times with sterile, ice-cold 0.9% NaCl. The red blood cells were then suspended in twice the volume of potassium phosphate, 12.5 mM, pH 7.4, and allow to lyse for 30 min. Then 2 volumes of ice-cold reagent-grade toluene was used to removed stroma lipid. Cellular debris was then separated by centrifugation at 15000ϫg for 2 hours at 4 o C. The sample was aliquoted and stored at Ϫ80 o C.
Preparation of Stroma-free Polyhemolysate
Polymerization of stroma-free haemoglobin was prepared according to Gu and Chang [21] . Polymerized 9.573 g/dL stroma-free hemolysate in 0.2mM sodium phosphate buffer, pH 7.4. Before crosslinking, 1.3 M of lysine was added at a molar ratio of 11.1:1 lysine/hemolysate. Crosslinking reaction began with the addition of glutaraldehyde (0.5 M) at a molar ratio of 16.1:1 glutaraldehyde/hemolysate by four equal aliquots over a period of 15 min. Crosslinking
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was continued for 24 hrs with constant stirring (140rpm) under aerobic conditions at 4 o C. The reaction was stopped by adding an excess of 1.3 M lysine monohydrochloride at a molar ratio of 1118:1 lysine/stroma-free hemolysate. Shaking was continued at 150rpm at 4 o C for 1h. Finally, the solution was centrifuged at 16,000ϫg for 1 hr and then stored at Ϫ80 o C to wait for the next step of purifi cation.
Purifi cation of Stroma-free Polyhemolysate
A Sephacryl-300 HR column (1.5cm*98 cm, V total ϭ560 ml) was prepared and equilibrated with 0.1M Tris-HCl and 0.15M NaCl pH 7.4 elution buffer. Samples (every 1.5ml) were passed through the column at a fl ow rate of 36 ml/hour. Standard catalase and tetrameric Hb peaks were determined by UV detector at 280nm (sensitivity "1"). This was to establish the exclusion for unlinked red blood cell enzymes such as catalase (250kDa), superoxide dismutase (32.5 kDa), and free tetrameric Hb (64kDa) by peak identifi cation using UV detector at 280nm and at room temperature. Based on this, only stroma-free polyhemolysate with molecular weights higher than 250kDa was collected, thereby excluding all free enzymes and tetrameric Hb. The stroma-free polyhemolysate samples were pooled and concentrated using a 100kDa ultracentrifugal fi lter. The Drabkin's method was used to analyze the hemolysate concentration of purifi ed stroma-free poly hemolysate. After this aliquots were stored at Ϫ80 o C.
Molecular Distribution of Stroma-free Polyhemolysate
The molecular weight distribution was recorded by a 280nm UV detector using the same gel fi ltration column at a recording velocity of 1mm/min and sensitivity "1."
We plotted the molecular weight peaks and calculated the area percentage of the two main peaks: a) the area of peak with molecular weight Ͼ66kDa; b) the area of peak with molecular weight Յ66kDa.
Measurements of CAT and SOD Activities
Three methods for catalase measurement were used in this paper: (1) UV 240nm spectrophotometeric method from the catalase assay kit (Sigma) measuring the rate of disappearance of H 2 O 2 ; (2) UV 240nm spectrophotometeric method [1] also monitor the decrease of H 2 O 2 level; and (3) Perborate titration method [17] to measure the decrease in perborate level. Superoxide dismutase activity was determined by Superoxide Dismutase kit (R&D Systems), which follows the inhibition of nitroblue tetrazolium (NBT) reduction using xanthine-xanthine oxidase used as a superoxide generator. 
Rat Immunization
Serum and Plasma Preparation
At week fi ve, four rats of each group (P, B and S) were anaesthetized (intraperitoneal injection of 5mg of pentobarbital per 100 gram body weight) and blood was collected by intra-cardiac puncture method.
(1) Plasma for complement activation studies: blood samples (one rat in each group) were quickly mixed with 10% (blood volume) heparin and centrifuged at 5500g for 20 min at 2 o C to obtain plasma. (2) Serum for Ouchterlony Double Diffusion Study: Collected blood samples were allowed to clot. After coagulation, the samples (three rats in each group) were centrifuged at 3,000g for 20 min at 4 o C to obtain serum. The (1) plasma samples and (2) serum samples were aliquoted as groups of P, B, and S and stored at Ϫ80 o C for the following studies.
C3a Complement Activation Test
Chang and Lister [10, 11] devised a simple screening method for blood substitutes using complement activation. Blood substitutes were added directly to plasma samples and increase in C3a was measured to see if there was any complement activation. Since then, this has been used for screening test of the purity and immunological properties of hemolysate-based oxygen carrier in both research and industrial production [6] . The detailed method is as described [6] .
Ouchterlony Double Diffusion Method
This Ouchterlony double diffusion method [16] was slightly used with slight modifi cation.
(1) Antibody-antigen reaction with free hemolysate, catalase, and superoxide dismutase:fi rst, 50μl of stroma-free hemolysate (1g/dl) was placed into each of the central wells of an 8% agarose gel plate (contains 2% sodium azide). Then 50μl of serum from group S1 (stroma-free hemolysate injected), group P1 (purifi ed stroma-free polyhemolysate injected) and group B1 (buffer injected) into two diagonally peripheral wells in duplicates, respectively (Fig. 1) . The same tests were carried out using serum from rats S2, S3, B2, B3 and P2, P3 in the same way. (2) Antibody-antigen reaction with polymerized polyHbStroma-free hemolysate (PolyHbcatalase-superoxide dismutase): stroma-free polyhemolysate is placed into the central well. Then 50μl of serum from group S1 (stroma-free hemolysate injected), group P1 (purifi ed stroma-free polyhemolysate injected) and group B1 (buffer injected) into two diagonally peripheral wells in duplicates, respectively (Fig. 1) . The same tests were carried out using serum from rats S2, S3, B2, B3 and P2, P3 in the same way. All plates were incubated at room temperature for four days. Digital photos of the plates were taken and analyzed for precipitation lines.
RESULTS AND DISCUSSIONS
Molecular Weight Distribution for Stroma-free Polyhemolysate
In order to judge the degree of polymerization, Sepacryl S-300 gel column chromatography was performed. The molecular weight distribution for stroma-free polyhemolysate showed three main components: the low molecular weight range (molecular weights less than 100 kDa containing tetrameric hemoglobin and demeric hemoglobin), the intermediate range (with molecular weights between 100 kDa and 600 kDa), and the high range (with molecular weights higher than 600 kDa) (Fig. 1) . After 24 hrs of cross-linking, the stroma-free polyhemolysate sample yielded 20% of polymer with molecular weight higher than 600 kDa, 53% of polymer with molecular weight between 100 kDa and 600 kDa, and 27% of sample with molecular weight lower than 100kDa. In total, there was about 73% stroma-free polyhemolysate with molecular weight higher than 100kDa. A size exclusion column [9] was used to remove those with molecular weight lower than 250kDa (Figure 2 ). This removed the following molecules: dimeric hemoglobin (33kDa), tetrameric hemoglobin (66kDa), free red blood cell enzymes such as cytochrome (12kDa), pyrimidine 5′-nucleotidase (28kDa), carbonic anhydrase (29kDa), superoxide dismutase (32.5 kDa), pyruvate kinase (57kDa), purine nucleoside phosphorylase (81kDa), glucose 6-phosphate dehydrogenase (240kDa) and catalase (240kDa) [14, 15, 22, 23, 24, 32, 34] .The resulting stroma-free polyhemolysate is then used in the immunological studies.
Dismutase Activity of Stroma-free Polyhemolysate
Two of the three methods were used. The result from the fi rst method based on the detection kits shows interference by the high concentration of the colored hemoglobin. The second method [1] was more precise for measuring catalase activity in the presence of high hemoglobin concentration. This method uses test samples as a blank to minimize hemoglobin interferences. Furthermore, the result was similar to the data measured by the titration method of Feinstein [17] using NaBO 3 as substrate that does not depend on color changes. The result from the Aebi method of measurement is shown in Table 1 . The superoxide dismutase activities were determined by SOD inhibition kits (R&D). Since stromafree polyhemolysate collected was only a portion of origin polymerized sample (molecular weight higher 250kDa), the SOD activity of stroma-free polyhemolysate was lower than that of stroma-free hemolysate. Stroma-free polyhemolysate Figure 1 . Molecular distribution of crosslinked bovine stroma-free polyhemolysate. The elution profi le of stromafree polyhemolysate was obtained by running 1 ml of stromafree polyhemolysate on Sepacryl S-300 1.5398cm column with 0.1 M Tris-Hcl, 0.15M NaCl pH 7.5 buffer at elution speed at 36 ml/hr. 
Effects on C3a Compliment Activity
The effect of stroma-free hemolysate and stroma-free polyhemolysate on C3a levels were studied. As shown in Table 2 , the amount of C3a des Arg in the control buffer immunized rat (0.42) was almost the same as the negative control (0.46). There was also no complement activation from the plasma of rats immunized with stroma-free hemolysate and stromafree polyhemolysate (0.15 and 0.18) as compared to the negative control (0.30 and 0.25), respectively. There were no signifi cant differences in C3a levels between the plasma incubated with stroma-free hemolysate, stroma-free polyhemolysate, and the saline control. C3a is a multifunctional, pro-infl ammatory mediator and has the ability to mediate hypersensitivity, anaphylactic reactions, and specifi c antibody-antigen responses. Complement activation has been used for screening contaminations in blood substitutes [9] [10] [11] . The activation of C3a is triggered by either classical or alternate complement pathways upon the hydrolyzation of protein C3. If any antibody is produced, the C3a will be activated and its stable form molecule, C3a des Arg, can be quantifi ed by ELISA assay. As shown in Table 1 , the amount of C3a des Arg in the buffer immunized rat (0.42) was almost the same as in the negative control (0.46). The C3a of stroma-free hemolysate and stroma-free polyhemolysate immunized rats (0.15 and 0.18) were lower than the negative control (0.30 and 0.25), respectively. The low amount of C3a des Arg indicated that fewer C3a was activated in all three groups of immunized rats. These results also demonstrated that fewer antigen specifi c antibodies, including specifi c anti-blood substitute antibody, were produced in rats. The low C3a activity demonstrated that no signifi cant amount of antibody was produced. 
Ouchterlony Double Diffusion Test
Ouchterlony's method was used for analyzing specifi c antibodies using antisera collected from each immunized rat (stroma-free hemolysate, stroma-free polyhemolysate, and buffer immunized rat). The undiluted antisera were incubated for 4 days with 1g/dl stroma-free hemolysate in azide containing agar gel (Fig. 2) . There did not appear to be an immunological response (i.e. no precipitin reaction in agar gel diffusion tests) between stroma-free hemolysate and antisera from all immunized rats. In order to test the immunological response between stroma-free polyhemolysate and antisera, another set of Ouchterlony tests were also performed. As shown in Fig. 2 , there was no precipitin reaction between 1g/dl stroma-free polyhemolysate and undiluted antisera from all immunized rats after 4 days of incubation.
CONCLUSIONS
Crosslinking of ultrapure hemoglobin, crystalline catalase and superoxide dismutase resulted in a soluble nanodimensional complex of Polyhemoglobin-catalse-superoxide dismutase [13] . This PolyHb-SOD-CAT has the ability to scavenge reactive oxygen species such as superoxide and hydrogen peroxide and has the ability to carry oxygen [13] . Additionally, investigations show that the use of the PolyHb-SOD-CAT leads to less disruption of the blood-brain barrier and less damage to liver, kidney, and intestine when compared to other oxygen-carrying solutions [31] . A less expensive and more convenient way is to follow the original use of red blood cell contents (stroma-free hemolysate) for the preparation of different types of hemoglobin-based blood substitutes [4, 5] . In this way, crosslinking stromafree hemolysate that already contains hemoglobin, catalase, and superoxide dismutase can result in the preparation of stroma-free polyhemolysate with catalase and superoxide dismutase activities (stroma-free polyhemolysate) [21] . The present study using C3a complement activation and Ouchterlony antibody-antigen precipitation shows that four weekly subcutaneous injections of bovine stroma-free polyhemolysate into rats did not result in any immunological reaction. These results are promising, especially if they can be supported by further studies.
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